Bharat Biotech & GSK to slash malaria vaccine price by over 50% by 2028, aiming for increased access in Africa. A major step ...

The vaccine, Mosquirix or RTS,S, was developed by GSK and the non-profit PATH, and was the first malaria vaccine to get ...

Drugmakers Bharat Biotech and GSK will reduce the price of their malaria vaccine, Mosquirix, to $5 per dose by 2028, more ...